The SymCHro - Observational Registry Study for Symbotex™ Composite Mesh in Ventral Hernia Repair (SymCHro)

October 14, 2019 updated by: Medtronic - MITG

Observational Registry Study for Symbotex™ Composite Mesh in Ventral Hernia Repair

The aim of this Observational Registry Study is to assess the short- and long-term clinical outcomes following the use of Symbotex™ Composite Mesh in primary and incisional abdominal wall hernia surgeries by open or laparoscopic approach, according to the Instruction for use (IFU).

Study Overview

Status

Completed

Detailed Description

This is an observational multicenter registry study. One hundred consecutive, adult patients scheduled for primary and incisional abdominal wall hernia surgeries using Symbotex™ Composite Mesh will be reported in the ClubHernie online database, with standard data captured of all preoperative, perioperative and post-operative data, for patient's outcomes measurements.

Primary Objective:

Evaluate the incidence of peri-operative and post-operative complications, with postoperative evaluations occurring, at discharge , 1 week (D1 and D8 follow up), 1 month (D30 follow up), 1 year and 2 year follow up after primary and incisional abdominal wall hernia surgeries using Symbotex™ Composite Mesh by open or laparoscopic approach (such as anticipated device related complications such as pain, recurrence, complications related to adhesions, wound complications, other postoperative complications, (SAE).

This online database consists of a systematic and consecutive data entry of all patients treated for Inguinal Hernia and Ventral Hernia by the 30 French surgeon members, with standard data captured of all preoperative, perioperative and post-operative data.

The database is required to be completed anonymously. Quality data control of all data captured into the online database will be performed by coherence analysis by Club Hernie authorized representative;A statistical analysis plan will be developed by Covidien.

Study reported device-related events will be reviewed periodically to assess for any potential trends

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montrouge, France, 92120
        • Club Hernie association represented by Dr Gillion, in his capacity as President

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

adult patients scheduled for primary and incisional abdominal wall hernia surgeries

Description

Inclusion Criteria:

  • The first one hundred consecutive adult patients scheduled for primary and incisional abdominal wall hernia surgery by Club Hernie members surgeons using Symbotex™Composite Mesh ;- All patients regardless of gender ≥ 18 years of age presenting with ventral hernias.
  • Patients will be informed by surgeon with a written information notice of the nature of the observational registry study.

Exclusion Criteria:

  • No exclusion criteria outside the product IFU

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1 GROUP
Only 1 group not predetermined

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Peri-operative and Post-operative Complications
Time Frame: Various (measured at 1 month, 1 Year & 2 Year)

Primary endpoint focuses on complications (including recurrence) occurring during procedure, and in short, mid and long-term (measured at 1 month, 1 year and 2 year follow-up respectively) following ventral hernia repair.

All peri-, intra- and post- operative complications

Various (measured at 1 month, 1 Year & 2 Year)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Assessment Measured With VAS Score
Time Frame: Various ( Baseline Day 0, Day 1, Day 8, Month 1, Month 3, 1 year , 2 year

Pain assessment measured with VAS* score

*VAS: The postoperative pain is assessed using a 0-10 Visual Analogue Scale. Worst pain experienced over the last 24 hours. Mild pain for VAS score between 0 and 3; Moderate pain for VAS score > 3 and > 6 ; Severe pain for VAS scores > 6

Various ( Baseline Day 0, Day 1, Day 8, Month 1, Month 3, 1 year , 2 year
Quality of Life for Patient
Time Frame: Various ( 1 Month, 1 year and 2 Year follow up)
Quality of Life of patients treated for ventral hernia For long-term follow up, two sets of self-administered Quality of Life (QOL) and patient satisfaction questionnaires were administered by phone call at 1 year and 2 year follow-up.
Various ( 1 Month, 1 year and 2 Year follow up)
Patient Satisfaction
Time Frame: Various (1 year and 2 year)
Patient satisfaction For long-term follow up, two sets of self-administered Quality of Life (QOL) and patient satisfaction questionnaires were administered by phone call at 1 year and 2 year follow-up.
Various (1 year and 2 year)
Surgeon Satisfaction (Mesh Handling, Mesh Manipulability, Ease of Use)
Time Frame: Day 0 Baseline
Mesh ease of use assessed by surgeons using Symbotex™ Composite Mesh for Patients treated for ventral hernia
Day 0 Baseline
Mesh Handling
Time Frame: Day 0 Baseline
ease of use / mesh Handling Mesh ease of use assessed by surgeons using Symbotex™ Composite Mesh for Patients treated for ventral hernia- Participant reflect surgeon who asses the feature of the mesh (for example, 68 surgeons agree that marking eases to place the mesh, 34 surgeons agree that the mesh is conformable to the anatomy etc..
Day 0 Baseline
The Use of Symbotex™ Composite Mesh During Surgery Hernia Repair
Time Frame: Baseline Day 0
Surgical technique approach for patients treated for ventral hernia with Symbotex™ Composite Mesh
Baseline Day 0
The Use of Symbotex™ Composite Mesh and Surgery Duration
Time Frame: Baseline Day 0
Operative Time (min) for patients treated for ventral hernia
Baseline Day 0
The Use of Symbotex™ Composite Mesh and Hospital Stay Duration
Time Frame: Baseline Day 0
Hospital stay (Days) for patients treated for ventral hernia with Symbotex Composite mesh device
Baseline Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean-François Gillion, ICMJE

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 25, 2014

Primary Completion (ACTUAL)

May 22, 2017

Study Completion (ACTUAL)

May 22, 2017

Study Registration Dates

First Submitted

July 21, 2014

First Submitted That Met QC Criteria

July 30, 2014

First Posted (ESTIMATE)

August 1, 2014

Study Record Updates

Last Update Posted (ACTUAL)

November 1, 2019

Last Update Submitted That Met QC Criteria

October 14, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ventral Incisional Hernia

3
Subscribe